SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001193125-22-246457
Filing Date
2022-09-16
Accepted
2022-09-16 16:56:57
Documents
15

Document Format Files

Seq Description Document Type Size
1 PRER14A d258714dprer14a.htm PRER14A 3176312
2 EX-FILING FEES d258714dexfilingfees.htm EX-FILING FEES 10668
3 GRAPHIC g258714g01a55.jpg GRAPHIC 202135
4 GRAPHIC g258714g15k08.jpg GRAPHIC 63209
5 GRAPHIC g258714g16p08.jpg GRAPHIC 207808
6 GRAPHIC g258714g59e42.jpg GRAPHIC 36932
7 GRAPHIC g258714g59z19.jpg GRAPHIC 33972
8 GRAPHIC g258714g64a01.jpg GRAPHIC 220084
9 GRAPHIC g258714g65a01.jpg GRAPHIC 104522
10 GRAPHIC g258714g66c22.jpg GRAPHIC 138164
11 GRAPHIC g258714g72a88.jpg GRAPHIC 109316
12 GRAPHIC g258714g91s91.jpg GRAPHIC 81854
13 GRAPHIC g258714g93d92.jpg GRAPHIC 27196
14 GRAPHIC g258714sbt1.jpg GRAPHIC 399217
15 GRAPHIC g258714sbt2.jpg GRAPHIC 264831
  Complete submission text file 0001193125-22-246457.txt   5760032
Mailing Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109
Business Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109 206-456-2900
Silverback Therapeutics, Inc. (Filer) CIK: 0001671858 (see all company filings)

IRS No.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRER14A | Act: 34 | File No.: 001-39756 | Film No.: 221248626
SIC: 2834 Pharmaceutical Preparations